Clinical Trials Logo

Circadian Rhythm Sleep Disorder clinical trials

View clinical trials related to Circadian Rhythm Sleep Disorder.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05618405 Recruiting - Anesthesia Clinical Trials

Changes in Circadian Rhythm After Anaesthesia in Children

CLOCKSkids
Start date: March 16, 2022
Phase:
Study type: Observational

In this study the investigators will examine the effect of general anesthesia and surgery on sleep duration and sleep quality in children, using questionnaires and a sleep diary.

NCT ID: NCT05569603 Recruiting - Clinical trials for Circadian Rhythm Sleep Disorder

Effects of Chronobiology-guided Lifestyle Interventions on Insomnia Severity, Cognitive Performance, and Sleepiness

Start date: January 12, 2022
Phase: N/A
Study type: Interventional

Poor sleep is closely related to circadian misalignment; shift workers often experience shift work disorder characterized by excessive sleepiness and recurrent shift work schedules-associated insomnia. This study aims to examine the effects of a program of chronobiology-guided lifestyle interventions (CGLI) on insomnia severity, cognitive performance (psychomotor vigilance and processing speed), and sleepiness in female nurses undertaking rotating-shift work.

NCT ID: NCT04690504 Recruiting - Sleep Disorder Clinical Trials

Validation of Circadian Biomarkers in Patients With Sleep Disorders

Start date: November 2, 2021
Phase:
Study type: Observational

Current methods for assessing circadian timing require sampling over hours (or even up to a day) while the patient is in controlled conditions. The investigators aim to develop a method that can estimate individual circadian time with a single blood sample taken at any time of the day or night. To do this, the investigators will use two state of the art methods, a plasma proteomics-based method to identify a panel of rhythmic proteins (extending our preliminary data) and a whole blood-derived monocyte-based method using a panel of 15 transcripts (to validate and extend a recent study). We will test both methods in a series of patients with circadian rhythm sleep disorders. We will validate separately the proteomics-based biomarker and the monocyte-based transcript biomarker, and also explore whether combining them can improve the accuracy of our timing estimates. In all cases, circadian phase estimates from the biomarker panels will be compared with those derived from plasma or saliva melatonin (the current "gold-standard" circadian phase marker).